Roundhill GLP-1 & Weight Loss ETF (OZEM)

OZEM Holdings Information

OZEM is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 19.37%, Novo Nordisk at 14.39%, Viking Therapeutics at 6.38%, Roche Holding AG at 5.62%, and Zealand Pharma at 5.57%.

• Total Holdings: 22
• Top 10 Percentage: 73.84%
• Asset Class: Equity
• ETF Category: Health
• Assets: 41.82M
• PE Ratio: 16.13

Top 25 Holdings

As of Dec 5, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	19.37%	8,059
2	NVO	Novo Nordisk A/S	14.39%	126,604
3	VKTX	Viking Therapeutics, Inc.	6.38%	69,815
4	SWX: ROG	Roche Holding AG	5.62%	6,125
5	ZEAL.DC	Zealand Pharma A/S	5.57%	29,756
6	4519.JP	Chugai Pharmaceutical Co Ltd	5.44%	41,900
7	GPCR	Structure Therapeutics Inc.	5.34%	68,588
8	AMGN	Amgen Inc.	4.03%	5,005
9	AZN	AstraZeneca PLC	3.86%	18,113
10	PFE	Pfizer Inc.	3.84%	63,053
11	HKG: 1801	Innovent Biologics, Inc.	3.69%	129,500
12	REGN	Regeneron Pharmaceuticals, Inc.	3.44%	2,008
13	KRX: 128940	Hanmi Pharm. Co., Ltd.	3.21%	4,647
14	SRRK	Scholar Rock Holding Corporation	3.07%	28,709
15	GUBRA.DC	Gubra A/S	2.76%	15,426
16	RYTM	Rhythm Pharmaceuticals, Inc.	1.88%	7,523
17	GILD	Gilead Sciences, Inc.	1.85%	6,378
18	HKG: 3933	The United Laboratories International Holdings Limited	1.73%	442,000
19	HKG: 1093	CSPC Pharmaceutical Group Limited	1.39%	596,000
20	4507.JP	Shionogi & Co Ltd	1.33%	32,300
21	BHVN	Biohaven Ltd.	1.20%	52,769
22	JPY	Lazard Japanese Equity ETF	0.01%	765,722